
    
      Primary Objective To determine Time to Chemotherapy Progression (ie includes time on Tarceva
      monotherapy and chemotherapy) in advanced NSCLC

      Secondary Objectives To evaluate survival and response rate associated with Tarceva treatment
      To study the frequency of symptom improvement (Lung Cancer Subscale)
    
  